Literature DB >> 22867844

Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles.

Ying-Chun Dai1, Yun-Yun Wang, Xu-Fu Zhang, Ming Tan, Ming Xia, Xian-Bo Wu, Xi Jiang, Jun Nie.   

Abstract

Noroviruses (NoVs) are a leading cause of epidemic acute gastroenteritis affecting millions of people worldwide. Understanding of NoV remains limited due to the lack of a cell culture system and small animal models. Currently, there are no effective vaccines or antivirals against NoVs. In this study, an approach for large-scale production of anti-NoV antibodies for use as a potential treatment for NoV disease using passive immunization was evaluated. NoV-specific immunoglobulins (IgYs) were produced by immunizing chickens with NoV P particles. The birds continuously produced high titers of antibodies in their eggs for at least 3months, in which NoV-specific antibody levels reached 4.7-9.2mg/egg yolk. The egg yolk antibodies strongly reacted with NoV P particles by both ELISA and Western blot and blocked NoV virus-like particle (VLP) and P particle binding to the histo-blood group antigen (HBGA) receptors with a BT(50) of about 1:800. The blocking activity of the chicken IgY remained after an incubation at 70°C for 30min or treatments at pH 4-9 for 3h. These data suggested that chicken IgY could be a practical strategy for large-scale production of anti-NoV antibodies for potential use as passive immunization against NoV infection, as well as for diagnostic purposes.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867844      PMCID: PMC3496071          DOI: 10.1016/j.jviromet.2012.07.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  22 in total

1.  Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns.

Authors:  Pengwei Huang; Tibor Farkas; Séverine Marionneau; Weiming Zhong; Nathalie Ruvoën-Clouet; Ardythe L Morrow; Mekibib Altaye; Larry K Pickering; David S Newburg; Jacques LePendu; Xi Jiang
Journal:  J Infect Dis       Date:  2003-06-12       Impact factor: 5.226

2.  Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns.

Authors:  Pengwei Huang; Tibor Farkas; Weiming Zhong; Ming Tan; Scott Thornton; Ardythe L Morrow; Xi Jiang
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Production of polyclonal antisera.

Authors:  Helen M Cooper; Yvonne Paterson
Journal:  Curr Protoc Neurosci       Date:  2009-07

4.  Library screen for inhibitors targeting norovirus binding to histo-blood group antigen receptors.

Authors:  Xizhi Feng; Xi Jiang
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

5.  The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors.

Authors:  Ming Tan; Xi Jiang
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Production and purification of Fab' fragments from chicken egg yolk immunoglobulin Y (IgY).

Authors:  E M Akita; S Nakai
Journal:  J Immunol Methods       Date:  1993-06-18       Impact factor: 2.303

7.  Anti-enteropathogenic Escherichia coli immunoglobulin Y isolated from eggs laid by immunised Leghorn chickens.

Authors:  J A Amaral; M Tino De Franco; M M S Carneiro-Sampaio; S B Carbonare
Journal:  Res Vet Sci       Date:  2002-06       Impact factor: 2.534

8.  Noroviral P particle: structure, function and applications in virus-host interaction.

Authors:  Ming Tan; Pingan Fang; Teepanis Chachiyo; Ming Xia; Pengwei Huang; Zhaoyin Fang; Wen Jiang; Xi Jiang
Journal:  Virology       Date:  2008-10-16       Impact factor: 3.616

9.  The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors.

Authors:  Ming Tan; Rashmi S Hegde; Xi Jiang
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 10.  Systematic literature review of role of noroviruses in sporadic gastroenteritis.

Authors:  Manish M Patel; Marc-Alain Widdowson; Roger I Glass; Kenichiro Akazawa; Jan Vinjé; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more
  18 in total

Review 1.  Vaccine against norovirus.

Authors:  Ming Tan; Xi Jiang
Journal:  Hum Vaccin Immunother       Date:  2014-05-05       Impact factor: 3.452

Review 2.  Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus.

Authors:  Ashraf Tabll; Aymn T Abbas; Sherif El-Kafrawy; Ahmed Wahid
Journal:  World J Hepatol       Date:  2015-10-08

3.  Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay.

Authors:  Ling Han; Elena N Kitova; Ming Tan; Xi Jiang; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2013-10-05       Impact factor: 3.109

4.  A dual chicken IgY against rotavirus and norovirus.

Authors:  Ying-Chun Dai; Xu-Fu Zhang; Ming Tan; Pengwei Huang; Wen Lei; Hao Fang; Weiming Zhong; Xi Jiang
Journal:  Antiviral Res       Date:  2012-12-22       Impact factor: 5.970

5.  The potency of chicken egg yolk immunoglobulin (IgY) specific as immunotherapy to Mycobacterium tuberculosis infection.

Authors:  Sri Agus Sudjarwo; Koerniasari Eraiko; Giftania Wardani Sudjarwo
Journal:  J Adv Pharm Technol Res       Date:  2017 Jul-Sep

6.  Chicken Egg Yolk Antibodies (IgY) for Prophylaxis and Treatment of Rotavirus Diarrhea in Human and Animal Neonates: A Concise Review.

Authors:  Hlaing Myat Thu; Theingi Win Myat; Mo Mo Win; Kyaw Zin Thant; Shofiqur Rahman; Kouji Umeda; Sa Van Nguyen; Faustino C Icatlo; Kyoko Higo-Moriguchi; Koki Taniguchi; Takao Tsuji; Keiji Oguma; Sang Jong Kim; Hyun Suk Bae; Hyuk Joon Choi
Journal:  Korean J Food Sci Anim Resour       Date:  2017-02-28       Impact factor: 2.622

7.  Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera.

Authors:  Ying-Chun Dai; Xu-Fu Zhang; Ming Xia; Ming Tan; Christina Quigley; Wen Lei; Hao Fang; Weiming Zhong; Bonita Lee; Xiaoli Pang; Jun Nie; Xi Jiang
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

8.  Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.

Authors:  Lorena Garaicoechea; Andrea Aguilar; Gabriel I Parra; Marina Bok; Stanislav V Sosnovtsev; Gabriela Canziani; Kim Y Green; Karin Bok; Viviana Parreño
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

Review 9.  Progress towards the prevention and treatment of norovirus infections.

Authors:  Armando Arias; Edward Emmott; Surender Vashist; Ian Goodfellow
Journal:  Future Microbiol       Date:  2013-11       Impact factor: 3.165

Review 10.  Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.

Authors:  Souvik Ghosh; Yashpal Singh Malik; Nobumichi Kobayashi
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.